Litcius/Paper detail

Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer

Luca Visani, Lorenzo Livi, Ivica Ratoša, Miha Oražem, Domen Ribnikar, Calogero Saieva, Carlotta Becherini, Viola Salvestrini, Erika Scoccimarro, Marianna Valzano, Cecilia Cerbai, Isacco Desideri, Marco Bernini, Lorenzo Orzalesi, Jacopo Nori, Simonetta Bianchi, Andrea Morandi, Icro Meattini

2022Radiotherapy and Oncology16 citationsDOIOpen Access PDF

Topics & Concepts

ConcomitantMedicineDiscontinuationInternal medicineAdverse effectBreast cancerOncologyMetastatic breast cancerGastroenterologyRadiation therapyUrologyCancerAdvanced Breast Cancer TherapiesBreast Cancer Treatment StudiesHER2/EGFR in Cancer Research
Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer | Litcius